Skip to main content

Advertisement

Log in

Design and evaluation of pyrimidine derivatives as potent inhibitors of ABCG2, a breast cancer resistance protein

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

The protein ATP-binding cassette subfamily G member 2 (ABCG2) is one of the major factors behind multidrug resistance (MDR) in breast cancer. We performed three-dimensional quantitative structure–activity relationship (3D-QSAR) modelling, docking, and molecular dynamics (MD) simulation to design pyrimidine-based ABCG2 antagonists. The developed QSAR model (r2 = 0.92, q2 = 0.82, and good cross-validated r2 = 0.73) dictate requirement of electrostatic, and hydrophobic fields for modulating bioactivity. Based on this rationale, we designed and screened 1010 new compounds, among them 2 (ND-510 and ND-500) exhibit excellent drug-like features. Comparative molecular docking, MM/GBSA and ADMET profiles were determined to understand the interactive poses, affinity, and drug-likeness of the designed compounds. Furthermore, MD simulations were performed with the ABCG2 receptor, and the results were compared with the two earlier synthesized active compounds. The outcomes of the study will help researchers to develop new antagonists for treatment of MDR breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Ahamad S, Hassan MI, Dwivedi N (2018) Designing of phenol-based β− carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach. 3 Biotech 8(5):1–18

    Article  CAS  Google Scholar 

  • Ahamad S, Islam A, Ahmad F, Dwivedi N, Hassan MI (2019) 2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives. Comput Biol Chem 78:398–413

    Article  CAS  Google Scholar 

  • Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD (2001) Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta BBA Gene Struct Expr 1520(3):234–241

    Article  CAS  Google Scholar 

  • Bauer MR (2018) Using Spark to design macrocycle BRD4 inhibitors

  • Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Krüger FA, Light Y, Mak L, McGlinchey S (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res 42(D1):D1083–D1090

    Article  CAS  Google Scholar 

  • Bhardwaj B, Baidya A, Amin S, Adhikari N, Jha T, Gayen S (2019) Insight into structural features of phenyltetrazole derivatives as ABCG2 inhibitors for the treatment of multidrug resistance in cancer. SAR QSAR Environ Res 30(7):457–475

    Article  CAS  Google Scholar 

  • Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L, Li J (2016) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370(1):153–164

    Article  CAS  Google Scholar 

  • Costantino C, Alba D, Cimino L, Conforto A, Mazzucco W (2021) The role of vaccination and screening in limiting the worldwide disease burden of preventable female cancers: a review. Women 1(1):16–28

    Article  Google Scholar 

  • Dean M, Hamon Y, Chimini G (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42(7):1007–1017

    Article  CAS  Google Scholar 

  • DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr 40(1):82–92

    Google Scholar 

  • Desmond S (2021) Schrödinger. Retrieved from https://www.schrodinger.com/desmond. Accessed 6 Oct 2021

  • Ejendal K, Hrycyna CA (2002) Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr Protein Pept Sci 3(5):503–511

    Article  CAS  Google Scholar 

  • Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF (2013) Acidity generated by the tumor microenvironment drives local invasion. Can Res 73(5):1524–1535

    Article  CAS  Google Scholar 

  • Gad SC (2014) QSAR. In: Third E (ed) Wexler PBT-encyclopedia of toxicology. Academic Press, Oxford, pp 1–9

    Google Scholar 

  • Homolya L, Orbán TI, Csanády L, Sarkadi B (2011) Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane. Biochim Biophys Acta (BBA) Biomembr 1808(1):154–163

    Article  CAS  Google Scholar 

  • Irwin JJ, Shoichet BK (2005) ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model 45(1):177–182

    Article  CAS  Google Scholar 

  • Jackson SM, Manolaridis I, Kowal J, Zechner M, Taylor NM, Bause M, Bauer S, Bartholomaeus R, Bernhardt G, Koenig B (2018) Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nat Struct Mol Biol 25(4):333–340

    Article  CAS  Google Scholar 

  • Kanipakam H, Sharma K, Thinlas T, Mohammad G, Pasha MQ (2021) Structural and functional alterations of nitric oxide synthase 3 due to missense variants associate with high-altitude pulmonary edema through dynamic study. J Biomol Struct Dyn 39(1):294–309

    Article  CAS  Google Scholar 

  • Katari SK, Natarajan P, Swargam S, Kanipakam H, Pasala C, Umamaheswari A (2016) Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations. J Recept Signal Transduction 36(6):558–571

    Article  CAS  Google Scholar 

  • Khunweeraphong N, Stockner T, Kuchler K (2017) The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion. Sci Rep 7(1):1–15

    Article  CAS  Google Scholar 

  • Krapf MK, Gallus J, Wiese M (2017) 4-Anilino-2-pyridylquinazolines and-pyrimidines as highly potent and nontoxic inhibitors of breast cancer resistance protein (ABCG2). J Med Chem 60(10):4474–4495

    Article  CAS  Google Scholar 

  • Krapf MK, Gallus J, Vahdati S, Wiese M (2018) New inhibitors of breast cancer resistance protein (ABCG2) containing a 2, 4-disubstituted pyridopyrimidine scaffold. J Med Chem 61(8):3389–3408

    Article  CAS  Google Scholar 

  • Kusuhara H, Sugiyama Y (2007) ATP-binding cassette, subfamily G (ABCG family). Pflügers Arch Eur J Physiol 453(5):735–744

    Article  CAS  Google Scholar 

  • Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26(2):283–291

    Article  CAS  Google Scholar 

  • Neves BJ, Braga RC, Melo-Filho CC, Moreira-Filho JT, Muratov EN, Andrade CH (2018) QSAR-based virtual screening: advances and applications in drug discovery. Front Pharmacol 9:1275

    Article  CAS  Google Scholar 

  • Parkali PM, Shyam Kumar A, Johanna KP, Prodensia TS, Turaga S, Shaiva V, Pujar GV, Joshi SD, Aminabhavi TM, Dixit SR (2021) Molecular docking and three-dimensional quantitative structure-activity relationships for antitubercular pyrimidine derivatives. Polycycl Aromat Compd. https://doi.org/10.1080/10406638.2021.1885455

    Article  Google Scholar 

  • Pasqualetto G, Schepelmann M, Varricchio C, Pileggi E, Khogali C, Morgan SR, Boostrom I, Rozanowska M, Brancale A, Ferla S (2020) Computational studies towards the identification of novel rhodopsin-binding compounds as chemical chaperones for misfolded opsins. Molecules 25(21):4904

    Article  CAS  Google Scholar 

  • Rawat N, Biswas P (2012) Hydrophobic moments, shape, and packing in disordered proteins. J Phys Chem B 116(22):6326–6335

    Article  CAS  Google Scholar 

  • Sharma R (2021) Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018. Breast Cancer Res Treat 187(2):557–567

    Article  Google Scholar 

  • Silbermann K, Stefan SM, Elshawadfy R, Namasivayam V, Wiese M (2019) Identification of thienopyrimidine scaffold as an inhibitor of the ABC transport protein ABCC1 (MRP1) and related transporters using a combined virtual screening approach. J Med Chem 62(9):4383–4400

    Article  CAS  Google Scholar 

  • Silbermann K, Li J, Namasivayam V, Baltes F, Bendas G, Stefan SM, Wiese M (2020) Superior pyrimidine derivatives as selective ABCG2 inhibitors and broad-spectrum ABCB1, ABCC1, and ABCG2 antagonists. J Med Chem 63(18):10412–10432

    Article  CAS  Google Scholar 

  • Silbermann K, Li J, Namasivayam V, Stefan SM, Wiese M (2021) Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel ABCG2 binding site. Eur J Med Chem 212:113045

    Article  CAS  Google Scholar 

  • Singh VK, Chaurasia H, Mishra R, Srivastava R, Naaz F, Kumar P, Singh RK (2022) Docking, ADMET prediction, DFT analysis, synthesis, cytotoxicity, antibacterial screening and QSAR analysis of diarylpyrimidine derivatives. J Mol Struct 1247:131400

    Article  CAS  Google Scholar 

  • Sivasankarapillai VS, Somakumar AK, Joseph J, Nikazar S, Rahdar A, Kyzas GZ (2020) Cancer theranostic applications of MXene nanomaterials: recent updates. Nano-Struct Nano-Objects 22:100457

    Article  CAS  Google Scholar 

  • Tadayon M, Garkani-Nejad Z (2019) In silico study combining QSAR, docking and molecular dynamics simulation on 2, 4-disubstituted pyridopyrimidine derivatives. J Recept Signal Transduction 39(2):167–174

    Article  CAS  Google Scholar 

Download references

Acknowledgements

SA is thankful for the IFTM University, Jamia Millia Islamia and Translational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology for providing the working environment and excellent infrastructure to peruse the doctorial research work.

Author information

Authors and Affiliations

Authors

Contributions

SA contributed to extensive in-silico exercises, MD simulations investigations, and original draft write-up in the manuscript. MIH contributed to corrections in the manuscript. DG contributed to review and corrections in the manuscript. ND contributed major inputs, reviews, and corrections in the manuscript. AI contributed to the final review, correspondence, and corrections in the manuscript.

Corresponding authors

Correspondence to Neeraj Dwivedi or Asimul Islam.

Ethics declarations

Conflict of interest

None of the authors have conflicts and declare no competing interests.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 4805 KB)

Supplementary file2 (DOCX 617 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmad, S., Hassan, M.I., Gupta, D. et al. Design and evaluation of pyrimidine derivatives as potent inhibitors of ABCG2, a breast cancer resistance protein. 3 Biotech 12, 182 (2022). https://doi.org/10.1007/s13205-022-03231-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-022-03231-1

Keywords

Navigation